Concepedia

Author

Sören Lehmann

Karolinska University HospitalORCID

Also Known As

H Garelius, Hultman, Christina M., S Lehmann, S. Lehmann, Soren Lehmann, Sören Lehmann, Sören Lehmann

172

Publications

7.6K

Citations

38

H-Index

75

Concepts

All Affiliations

Karolinska University HospitalKarolinska InstitutetUppsala UniversityUppsala University HospitalSkåne University Hospital
SL

About

Sören Lehmann is an author at Karolinska University Hospital specializing in medicine, hematology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

25

1.6K

2

Health Sciences

5

5

431

3

Engineering

3

3

159

4

Public Health

3

3

178

5

Natural Sciences

2

2

102

Sören Lehmann

×

63

Publications

7.2K

Citations

34

H-Index

YearCitations

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Giulio Genovese, Anna K. Kähler, Robert E. Handsaker,

New England Journal of Medicine

2014

3.4K

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Sören Lehmann, Vladimir J.N. Bykov, Dina Ali,

Journal of Clinical Oncology

2012

397

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

Anders Castor, Lars Nilsson, Ingbritt Åstrand‐Grundström,

Nature Medicine

2005

328

Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: <scp>A</scp> report from the <scp>S</scp>wedish <scp>A</scp>cute <scp>L</scp>eukemia <scp>R</scp>egistry

Erik Hulegårdh, Christer Nilsson, Vladimir Lazarević,

American Journal of Hematology

2014

271

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums,

Leukemia

2016

239

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

Nikolas Herold, Sean G. Rudd, Linda Ljungblad,

Nature Medicine

2017

141

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Martin Höglund, Fredrik Sandin, Karin Hellström,

Blood

2013

127

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia

Stefan Deneberg, Michael Grövdal, Mohsen Karimi,

Leukemia

2010

119

Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Linus Angenendt, Christoph Röllig, Pau Montesinos,

Journal of Clinical Oncology

2019

113

Expression levels of long non-coding RNAs are prognostic for AML outcome

Arvind Singh Mer, Johan Lindberg, Christer Nilsson,

Journal of Hematology & Oncology

2018

97

Page 1